This month, AIRC, IDIBELL, Eda 6 and Helmholtz Munich celebrate the end of the innovative Erasmus+ science outreach project STARS Game, where high school students, teachers and scientists from Italy, Spain, Slovenia and Germany conducted workshops and developed together an immersive digital escape room.
Successful conclusion of STARS Game, an innovative science education project Read More »
Last Friday, November 10, the eighth edition of the IDIBELL PhD Day was held at the Faculty of Medicine and Health Sciences at the UB Bellvitge Campus. This event, which takes place anually, is organized by the PhD Committee in collaboration with different IDIBELL units and aims to encourage the sharing of ideas and foster
The 8th PhD Day puts a spotlight on mental health in the research career Read More »
An international consortium, with the collaboration of Alberto Villanueva’s team at IDIBELL and the Catalan Institute of Oncology, and the Vall d’Hebron Hospital, has generated a collection of pediatric cancer models in mice based on the tumors in children that will allow the effectiveness of treatments to be tested before administering them to patients.
A new advance in the fight against childhood cancer Read More »
Four IDIBELL research groups receive funding from La Marató 3Cat dedicated to cardiovascular diseases. Ángel Raya, José López, Cristina Enjuanes and Ignasi Anguera are the principal investigators who will carry out the research projects awarded by La Marató 2022.
During the month of November, customers of this supermarket chain will be able to round up their purchases and collaborate with research against this disease.
14% of adults and 12% of children are addicted to this type of food. Its composition and presentation activate reward neural circuits similarly to alcohol or tobacco.
Ultra-processed foods, one of the main addictions for children today Read More »
The association has reached an agreement to undertake a strategic collaboration in order to develop a project to study the biology of glucocorticoids in the origin and evolution of Lymphangioleiomyomatosis.
AELAM donates 15.000€ to research on Lymphangioleiomyomatosis Read More »
This finding, published in the International Journal of Antimicrobial Agents, highlights the possibility that this resistance mechanism could spread to other sexually transmitted pathogens.
EATRIS, the European Infrastructure for Translational Medicine, has just announced its participation in the stakeholders’ advisory group in the ‘COMBINE’ project, an initiative aimed at providing clarity and alignment at the interface between clinical trials of investigational medicinal products, performance studies of in vitro diagnostics, and clinical investigations of medical devices. COMBINE is an
The IDIBELL research group on immunoinflammatory processes demonstrates that the C4BP (β-) protein could be a promising therapeutic option for inflammatory bowel disease.
